(AG99)

Buy:
10,210.00 p
Sell:
9,935.00 p
Change:
text-danger
-0.38 (-0.37%)

Glaxosmithkline Capital 5.25% Gtd Nts 19/12/33 (AG99)

Glaxosmithkline Capital 5.25% Gtd Nts 19/12/33 (AG99)

ISIN:

XS0140516864

Trading on:

London Stock Exchange

Buy:
10,210.00 p
Sell:
9,935.00 p
Change:
text-danger
-0.37 (-0.37%)
Updated at: 20-07-2026 - 16:05
*Prices delayed by at least 15 minutes
At a glance

At a glance performance and information

Trading update:

Opening price:

10,075.00 p

Previous close:

10,117.50 p

Day High / Low:

10,132.40 p - 10,072.50 p

Volume:

0

52 week High / Low:

10,542.50 p - 9,995.00 p

Fundamentals:

Currency:

GBP

Maturity date:

19/12/2033

Running Yield:

0.05

Eligibility:

Share Dealing Account Yes
ISA Yes
SIPP Yes

Investing for longer increases the likelihood of positive returns. Over a period of 5 years or more, investments usually give you a higher return compared to cash savings. But investments can go down as well as up in value. So you could get back less than you put in.

Fees & charges

Fees and Charges

Fees and Charges
Charge Who receives this? What is it? Amount
Dealing commission: Scottish Widows The cost of buying or selling some or all of your investment. £5.00 (per online trade)

*This is an indication based on the market average. The fund’s actual transaction cost will be shown before you place a trade.

Account charges are not included